Nuzenio

Gene Technology Limited

Gene Technology Limited news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Bio-Gene Technology Issues 69.2 Million Unquoted Options Expiring October 2027 - KalkineKalkine · Mon, 10 Aug 2026 03:59:55 GMTBio-Gene Technology Directors Timothy Grogan and Andrew Guthrie Acquire Shares and Options Under Placement - KalkineKalkine · Mon, 10 Aug 2026 03:41:32 GMTBio-Gene Technology Applies for Quotation of 34.76 Million Ordinary Shares at $0.025 - KalkineKalkine · Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Applies to Quote 2 Million Shares Issued for Investor Relations Services - KalkineKalkine · Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Applies to Quote 15.22 Million SPP Underwriter Shares at $0.025 - KalkineKalkine · Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Seeks ASX Listing for 34.76 Million Shares at $0.025 Each - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 03:08:13 GMTBGT:ASX Announcement - Results of Meeting - 05 Aug 2026 - Market IndexMarket Index · Wed, 05 Aug 2026 07:00:00 GMTBio-Gene Technology Limited Secures Unanimous Approval on All 11 Resolutions at 2026 Extraordinary General Meeting - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 03:06:30 GMT

Timeline

Mon, 10 Aug 2026 03:59:55 GMTBio-Gene Technology Issues 69.2 Million Unquoted Options Expiring October 2027 - Kalkine
Mon, 10 Aug 2026 03:41:32 GMTBio-Gene Technology Directors Timothy Grogan and Andrew Guthrie Acquire Shares and Options Under Placement - Kalkine
Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Applies for Quotation of 34.76 Million Ordinary Shares at $0.025 - Kalkine
Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Applies to Quote 2 Million Shares Issued for Investor Relations Services - Kalkine
Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Applies to Quote 15.22 Million SPP Underwriter Shares at $0.025 - Kalkine
Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Seeks ASX Listing for 34.76 Million Shares at $0.025 Each - Kalkine Media

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gene Technology Limited.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.